Thromboembolic Events Among Patients Hospitalized With COVID-19 Pneumonia
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Medulloblastoma survivors had an increased risk of long-term adverse outcomes.
Sedentary time, longer bouts in particular, may increase risk for stroke.
Researchers sought to compare the efficacy of momelotinib with danazol in patients with thrombocytopenic myelofibrosis who were symptomatic and anemic.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
As part of stroke recovery program, modified cardiac rehab may lower all-cause one-year mortality, improve overall and cardiovascular function.
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Researchers are seeking to address the psychological impact of patients who have survived VTE.
A study compared patients with diffuse large B-cell lymphoma with a 1:10 cohort from the general population to determine the risk of cardiovascular events in patients receiving doxorubicin-containing regimens.
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.